Electra Therapeutics (ETRA) vs ProKidney (PROK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ProKidney is the larger company by market cap ($626.7 million vs $574.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETRA | PROK |
|---|---|---|
| Share price | $9.16 | $1.57 |
| Market cap | $574.95M | $626.72M |
| 1-day change | -6.72% | -1.88% |
| YTD return | — | -29.91% |
| 1-year return | — | -46.96% |
| 5-year return | — | -84.09% |
| EPS (TTM) | $-2.65 | $-0.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.50 | $3.48 |
| 52-week low | $8.92 | $1.30 |
| Distance from 52-week high | -40.90% | -54.89% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +298.09% |
| Average volume | 990.55K | 1.31M |
| Shares outstanding | 62.77M | 208.93M |
| Employees | 46 | 231 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Electra Therapeutics
ETRA stock →Electra Therapeutics, Inc. is a clinical-stage biotechnology company.
Healthcare · Biotechnology · 46 employees
About ProKidney
PROK stock →ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes.
Healthcare · Biotechnology · 231 employees
ETRA vs PROK FAQ
Which is bigger, Electra Therapeutics or ProKidney?
ProKidney (PROK) is larger, with a market capitalization of $626.72M compared with $574.95M for Electra Therapeutics (ETRA).
Are Electra Therapeutics and ProKidney in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.